Skip to main content
Erschienen in: Pediatric and Developmental Pathology 1/2004

01.02.2004 | Original Article

Cardiac, Aortic, and Pulmonary Arteriopathy in HIV-infected children: The Prospective P2C2 HIV Multicenter Study

verfasst von: A.R. Perez-Atayde, D.I. Kearney, J.T. Bricker, S.D. Colan, K.A. Easley, S. Kaplan, W.W. Lai, S.E. Lipshultz, D.S. Moodie, G. Sopko, T.J. Starc, for the P2C2 HIV Study Group

Erschienen in: Pediatric and Developmental Pathology | Ausgabe 1/2004

Einloggen, um Zugang zu erhalten

Abstract

Arteriopathy in human immunodeficiency virus (HIV)-infected patients is being increasingly recognized, especially in children. However, few studies have histologically evaluated the coronary arteries in HIV-infected children, and none have systematically assessed the aorta and pulmonary arteries. The coronary arteries, thoracic aorta, and the main and branch pulmonary arteries from the postmortem hearts of 14 HIV-infected children were systematically reviewed for vasculopathic lesions and compared with 14 age-matched controls. Findings from the HIV-infected children were compared with clinical, laboratory, and other postmortem findings. Coronary arteriopathy, seen in seven (50%) of the HIV-infected children, was primarily calcific, and it was associated with decreased CD3 and CD4 peripheral blood counts. Large vessel arteriopathy, seen in 9 (64%) of the 14 HIV-infected children, was primarily centered on the vasa vasorum and consisted mainly of medial hypertrophy and chronic inflammation. Large vessel lesions were associated with increased left ventricular mass z-scores (P = 0.02), and 78% of patients with large vessel arteriopathy had postmortem cardiomegaly. Coronary and large vessel arteriopathies are common in pediatric HIV-infection and have different clinicopathologic features suggesting different pathogenesis.
Literatur
1.
Zurück zum Zitat Joshi, VV, et al. 1987Arteriopathy in children with acquired immune deficiency syndromePediatr Pathol7261275AUTHOR: On all references journal style requires listing all authors up to 6 names; if 7 authors or more, list first 3 names before et al. can usedPubMed Joshi, VV,  et al. 1987Arteriopathy in children with acquired immune deficiency syndromePediatr Pathol7261275AUTHOR: On all references journal style requires listing all authors up to 6 names; if 7 authors or more, list first 3 names before et al. can usedPubMed
2.
Zurück zum Zitat Tabib, A, et al. 2000Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patientsCoron Artery Dis114146CrossRefPubMed Tabib, A,  et al. 2000Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patientsCoron Artery Dis114146CrossRefPubMed
3.
5.
Zurück zum Zitat Shingadia, D, et al. 1999Takayasu’s arteritis in a human immunodeficiency virus-infected adolescentClin Infect Dis29458459PubMed Shingadia, D,  et al. 1999Takayasu’s arteritis in a human immunodeficiency virus-infected adolescentClin Infect Dis29458459PubMed
6.
Zurück zum Zitat Gallet B, et al. Vascular complications associated with use of HIV protease inhibitors (Letter; Comment). Lancet 1998; 351:1958–1959 Gallet B, et al. Vascular complications associated with use of HIV protease inhibitors (Letter; Comment). Lancet 1998; 351:1958–1959
7.
Zurück zum Zitat Henry K, et al. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities (Letter; Comments). Lancet 1998; 352:1031–1032 Henry K, et al. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities (Letter; Comments). Lancet 1998; 352:1031–1032
8.
Zurück zum Zitat Henry K, et al. Severe premature coronary artery disease with protease inhibitors (Letter; Comments). Lancet 1998; 351–1328 Henry K, et al. Severe premature coronary artery disease with protease inhibitors (Letter; Comments). Lancet 1998; 351–1328
9.
Zurück zum Zitat Karmochkine M, Raguin G. Severe coronary artery disease in a young HIV-infected man with no cardiovascular risk factor who was treated with indinavir (Letter). AIDS 1998; 12–2499 Karmochkine M, Raguin G. Severe coronary artery disease in a young HIV-infected man with no cardiovascular risk factor who was treated with indinavir (Letter). AIDS 1998; 12–2499
10.
Zurück zum Zitat Vittecoq D, Escaut L, Monsuez JJ. Vascular complications associated with use of HIV protease inhibitors (Letter; Comment). Lancet 1998; 351–1959 Vittecoq D, Escaut L, Monsuez JJ. Vascular complications associated with use of HIV protease inhibitors (Letter; Comment). Lancet 1998; 351–1959
11.
Zurück zum Zitat Duong, M, et al. 2002Exercise stress testing for detection of silent myocardial ischemia in human immunodeficiency virus-infected patients receiving antiretroviral therapyClin Infect Dis34523528PubMed Duong, M,  et al. 2002Exercise stress testing for detection of silent myocardial ischemia in human immunodeficiency virus-infected patients receiving antiretroviral therapyClin Infect Dis34523528PubMed
12.
Zurück zum Zitat Anonymous1996The pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus (P2C2 HIV) infection study: design and methods. The P2C2 HIV Study GroupJ Clin Epidemiol4912851294 Anonymous1996The pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus (P2C2 HIV) infection study: design and methods. The P2C2 HIV Study GroupJ Clin Epidemiol4912851294
13.
Zurück zum Zitat Bowles, NE, et al. 1999The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV diseaseJ Am Coll Cardiol34857865CrossRefPubMed Bowles, NE,  et al. 1999The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV diseaseJ Am Coll Cardiol34857865CrossRefPubMed
14.
Zurück zum Zitat Lipshultz, SE, et al. 1998Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study GroupCirculation9712461256PubMed Lipshultz, SE,  et al. 1998Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study GroupCirculation9712461256PubMed
15.
Zurück zum Zitat Kearney, DL, Popek, EJ 1997Cardiovascular systemMullick, CMaFG eds. Systemic Pathology of HIV Infection and AIDS in ChildrenAmerican Registry of Pathology, Armed Forces Institute of PathologyWashington, DC.. Kearney, DL, Popek, EJ 1997Cardiovascular systemMullick, CMaFG eds. Systemic Pathology of HIV Infection and AIDS in ChildrenAmerican Registry of Pathology, Armed Forces Institute of PathologyWashington, DC..
16.
Zurück zum Zitat Sato, S, Sueki, H, Nishijima, A 1999Two unusual cases of argyria: the application of an improved tissue processing method for X-ray microanalysis of selenium and sulphur in silver-laden granulesBr J Dermatol140158163CrossRefPubMed Sato, S, Sueki, H, Nishijima, A 1999Two unusual cases of argyria: the application of an improved tissue processing method for X-ray microanalysis of selenium and sulphur in silver-laden granulesBr J Dermatol140158163CrossRefPubMed
17.
Zurück zum Zitat Chadwick EG, et al. Coronary vasculopathy (CV) is common in children with end-stage perinatally acquired HIV infections: a study of 18 autopsy cases (session 72, Abstract 719). Fourth Conference on Retroviruses and Opportunistic Infections, Washington DC, 1997 Chadwick EG, et al. Coronary vasculopathy (CV) is common in children with end-stage perinatally acquired HIV infections: a study of 18 autopsy cases (session 72, Abstract 719). Fourth Conference on Retroviruses and Opportunistic Infections, Washington DC, 1997
18.
Zurück zum Zitat Kabus, D, Greco, MA 1991Arteriopathy in children with AIDS: microscopic changes in the vasa vasorum with gross irregularities of the aortic intima [letter]Pediatr Pathol11793795PubMed Kabus, D, Greco, MA 1991Arteriopathy in children with AIDS: microscopic changes in the vasa vasorum with gross irregularities of the aortic intima [letter]Pediatr Pathol11793795PubMed
19.
Zurück zum Zitat Marks, C, Kuskov, S 1995Pattern of arterial aneurysms in acquired immunodeficiency diseaseWorld J Surg19127132PubMed Marks, C, Kuskov, S 1995Pattern of arterial aneurysms in acquired immunodeficiency diseaseWorld J Surg19127132PubMed
20.
Zurück zum Zitat Chetty, R, Batitang, S, Nair, R 2000Large artery vasculopathy in HIV-positive patients: another vasculitic enigmaHum Pathol31374379PubMed Chetty, R, Batitang, S, Nair, R 2000Large artery vasculopathy in HIV-positive patients: another vasculitic enigmaHum Pathol31374379PubMed
Metadaten
Titel
Cardiac, Aortic, and Pulmonary Arteriopathy in HIV-infected children: The Prospective P2C2 HIV Multicenter Study
verfasst von
A.R. Perez-Atayde
D.I. Kearney
J.T. Bricker
S.D. Colan
K.A. Easley
S. Kaplan
W.W. Lai
S.E. Lipshultz
D.S. Moodie
G. Sopko
T.J. Starc
for the P2C2 HIV Study Group
Publikationsdatum
01.02.2004
Verlag
Springer-Verlag
Erschienen in
Pediatric and Developmental Pathology / Ausgabe 1/2004
Print ISSN: 1093-5266
Elektronische ISSN: 1615-5742
DOI
https://doi.org/10.1007/s10024-003-1001-9

Weitere Artikel der Ausgabe 1/2004

Pediatric and Developmental Pathology 1/2004 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …